XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
 Psychiatry
 Genetics
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
  AIDS
  Influenza
  MRSA
  Tuberculosis
  Shigella
  HCV
  SARS
  Ebola
  Dengue
  Malaria
  Pertussis
  Mumps
  Prion Diseases
  Small Pox
  Anthrax
  Leishmaniasis
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
Search

Last Updated: Aug 19th, 2006 - 22:18:38
Announcement

Infectious Diseases Channel
subscribe to Infectious Diseases newsletter

Latest Research : Infectious Diseases

   DISCUSS   |   EMAIL   |   PRINT
"Sniffing out infection"
Mar 15, 2006, 00:42, Reviewed by: Dr. Sanjukta Acharya

Professor Krishna Persaud, of The University of Manchester's School of Chemical Engineering and Analytical Science, who will coordinate the European-wide project, said:"Our aim is to produce a non-invasive system that can monitor the state of a patient's wounds simply by detecting bad bacteria in the air emitted from the wound. Using state of the sensors we will be able to detect and diagnose the presence of an infection almost instantaneously."

 
The University of Manchester has received �1m (�1.67m) to develop a new device able to 'sniff out' harmful infections.
The funding will be used to create a non-invasive wound monitor to treat patients with severe burns, skin ulcers or gaping wounds.

The aim is to produce a device which is able to detect harmful bacteria in the air, which may signal the first signs of infection. When bacteria metabolises inside a wound molecules of that bacteria are emitted into the air.

Current methods rely on medical staff taking swabs from a wound and testing them in a lab, which can take several days.

Professor Krishna Persaud, of The University of Manchester's School of Chemical Engineering and Analytical Science, who will coordinate the European-wide project, said: "Current methods make it difficult to detect infections at an early stage and can be extremely invasive causing the patient a great deal of discomfort".

"Our aim is to produce a non-invasive system that can monitor the state of a patient's wounds simply by detecting bad bacteria in the air emitted from the wound. Using state of the sensors we will be able to detect and diagnose the presence of an infection almost instantaneously."

The device will use new hybrid sensor technology with a mobile laboratory-based multi-technology gas sensor array and pattern recognition system, enabling the rapid analyses of molecules in the air. It is envisaged that the monitor will be take the form of a mobile unit which sits alongside other monitoring equipment next to the patient.

Key applications for the device will include monitoring trauma injuries, chronic ulcers and in military field hospitals.

Manchester will coordinate a European team of engineers and medical experts, which will include consultants from the Department of Burns and Plastic Surgery at Wythenshawe Hospital (Manchester) and Kaunas Medical University Hospital (Lithuania). The three year project is funded by the European Commission with the aim of delivering a prototype device by the end of the project.

 

- University of Manchester
 

 
Subscribe to Infectious Diseases Newsletter
E-mail Address:

 

The project was launched on February 23 when all of the scientific, clinical and commercial partners met in Manchester.

Partners include: Puslaidininkiu Fizikos Institutas, Lithuania, Kaunas Medical University Hospital, Lithuania, CNR-Istituto Nazionale per la Fisica della Materia, Brescia, Italy, Biodiversity SPA, Italy, Umwelt-Systemtechnik GmbH, Germany, and the Department of Burns and Plastic Surgery at South Manchester University Hospitals Trust.

The School of Chemical Engineering and Analytical Science is part of The University of Manchester's Faculty of Engineering and Physical Sciences


Related Infectious Diseases News

Keeping A3G in action represents a new way to attack HIV
Fighting HIV With HIV Virus Itself
Retina can provide a very reliable way of diagnosing cerebral malaria
Are influenza vaccines worth the effort?
A light daily exercise program may reduce the incidence of colds
HIV exploits competition among T-cells
Mass vaccination would not be necessary in the event of a smallpox bioterrorist attack
How Ebola and Marburg viruses cause disease
Transmission of MRSA Linked to Previous Intensive Care Unit Room Occupants
Harmless GB Virus type C (GBV-C) protects against HIV infection


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us